These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 33662596)
21. Noncontrast MRI with diffusion-weighted imaging as the sole imaging modality for detecting liver malignancy in patients with high risk for hepatocellular carcinoma. Kim YK; Kim YK; Park HJ; Park MJ; Lee WJ; Choi D Magn Reson Imaging; 2014 Jul; 32(6):610-8. PubMed ID: 24702980 [TBL] [Abstract][Full Text] [Related]
22. The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study. Han S; Choi JI; Park MY; Choi MH; Rha SE; Lee YJ Korean J Radiol; 2018; 19(4):568-577. PubMed ID: 29962863 [TBL] [Abstract][Full Text] [Related]
23. The clinical value of dual-energy computed tomography and diffusion-weighted imaging in the context of liver cancer: A narrative review. Fan PL; Chu J; Wang Q; Wang C J Clin Ultrasound; 2022 Jul; 50(6):862-868. PubMed ID: 35338779 [TBL] [Abstract][Full Text] [Related]
24. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies. Li J; Wang J; Lei L; Yuan G; He S Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172 [TBL] [Abstract][Full Text] [Related]
25. A pooled analysis of diffusion-weighted imaging in the diagnosis of hepatocellular carcinoma in chronic liver diseases. Wu LM; Xu JR; Lu Q; Hua J; Chen J; Hu J J Gastroenterol Hepatol; 2013 Feb; 28(2):227-34. PubMed ID: 23190006 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic Performance of Liver Imaging Reporting and Data System Version 2017 Versus Version 2018 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Comparative Studies. Kim YY; Lee S; Shin J; Son WJ; Shin H; Lee JE; Hwang JA; Chung YE; Choi JY; Park MS J Magn Reson Imaging; 2021 Dec; 54(6):1912-1919. PubMed ID: 33929784 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis. Liang Y; Xu F; Guo Y; Lai L; Jiang X; Wei X; Wu H; Wang J Eur J Radiol; 2021 Jan; 134():109404. PubMed ID: 33276248 [TBL] [Abstract][Full Text] [Related]
28. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis. Xu PJ; Yan FH; Wang JH; Lin J; Ji Y J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186 [TBL] [Abstract][Full Text] [Related]
29. CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis. Lee S; Kim YY; Shin J; Hwang SH; Roh YH; Chung YE; Choi JY J Am Coll Radiol; 2020 Oct; 17(10):1199-1206. PubMed ID: 32640250 [TBL] [Abstract][Full Text] [Related]
30. Mean ADC values and arterial phase hyperintensity discriminate small (≤ 3 cm) well-differentiated hepatocellular carcinoma from dysplastic nodule. Zong X; Li M; Li J; Chen Q; Shi A; Gao X; Guo R Abdom Radiol (NY); 2024 Apr; 49(4):1132-1143. PubMed ID: 38289351 [TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid. Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837 [TBL] [Abstract][Full Text] [Related]
32. Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging. Min JH; Kim YK; Choi SY; Kang TW; Jeong WK; Kim K; Won HJ Br J Radiol; 2018 Oct; 91(1090):20180177. PubMed ID: 29927634 [TBL] [Abstract][Full Text] [Related]
33. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors. Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756 [TBL] [Abstract][Full Text] [Related]
34. Abbreviated MRI for Hepatocellular Carcinoma Surveillance - A Systematic Review and Meta-analysis. Maung ST; Deepan N; Decharatanachart P; Chaiteerakij R Acad Radiol; 2024 Aug; 31(8):3142-3156. PubMed ID: 38413315 [TBL] [Abstract][Full Text] [Related]
35. Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease? Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhu J; Zhang W; Hu J Dig Dis Sci; 2013 Nov; 58(11):3313-25. PubMed ID: 23884757 [TBL] [Abstract][Full Text] [Related]
36. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Wu LM; Hu J; Gu HY; Hua J; Xu JR Eur J Cancer; 2013 Feb; 49(3):572-84. PubMed ID: 23000072 [TBL] [Abstract][Full Text] [Related]
37. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial? Zhao XT; Li WX; Chai WM; Chen KM J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621 [TBL] [Abstract][Full Text] [Related]
38. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis. Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316 [TBL] [Abstract][Full Text] [Related]
39. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard. Hardie AD; Kizziah MK; Rissing MS J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541 [TBL] [Abstract][Full Text] [Related]
40. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis. Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]